Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Bluestone

Showing results (41-50 of 276) with videos related to

Pageof 28
Sort By:
The Journal of Experimental Medicine|June 1, 1993
Tolerance of T cell receptor gamma/delta cells in the intestineT A Barrett, Y Tatsumi, J A Bluestone
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospectsS M Kang, Q Tang, J A Bluestone
The Journal of Experimental Medicine|June 13, 1998
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptorL A Chau, J A Bluestone, J Madrenas
The Journal of Experimental Medicine|April 1, 1986
Cloned cytotoxic T lymphocytes that recognize an I-A region product in the context of a class I antigenN Shinohara, J A Bluestone, D H Sachs
Lancet (London, England)|June 17, 1989
Anti-CD3 antibody for autoimmune disease, a cautionary noteR Hirsch, R E Gress, J A Bluestone
The New England Journal of Medicine|August 16, 1990
Neurotoxicity after treatment with muromonab-CD3J M Richards, N J Vogelzang, J A Bluestone
Immunologic Research|February 1, 1997
CD28/B7 regulation of autoimmune diabetesK G Herold, D J Lenschow, J A Bluestone
Immunogenetics|January 1, 1990
Polymorphisms and diversity of T-cell receptor-gamma proteins expressed in mouse spleenR Q Cron, J E Coligan, J A Bluestone
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Activation of T cells in vivo using anti-CD3 and staphylococcal enterotoxinsJ A Bluestone, D S Bruce, K A Newell
Digestive Diseases and Sciences|January 1, 1995
Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptorsM L Alegre, D J Lenschow, J A Bluestone
Pageof 28

Showing results (41-50 of 276) with videos related to

Sort By:
Pageof 28
The Journal of Experimental Medicine|June 1, 1993
Tolerance of T cell receptor gamma/delta cells in the intestineT A Barrett, Y Tatsumi, J A Bluestone
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospectsS M Kang, Q Tang, J A Bluestone
The Journal of Experimental Medicine|June 13, 1998
Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptorL A Chau, J A Bluestone, J Madrenas
The Journal of Experimental Medicine|April 1, 1986
Cloned cytotoxic T lymphocytes that recognize an I-A region product in the context of a class I antigenN Shinohara, J A Bluestone, D H Sachs
Lancet (London, England)|June 17, 1989
Anti-CD3 antibody for autoimmune disease, a cautionary noteR Hirsch, R E Gress, J A Bluestone
The New England Journal of Medicine|August 16, 1990
Neurotoxicity after treatment with muromonab-CD3J M Richards, N J Vogelzang, J A Bluestone
Immunologic Research|February 1, 1997
CD28/B7 regulation of autoimmune diabetesK G Herold, D J Lenschow, J A Bluestone
Immunogenetics|January 1, 1990
Polymorphisms and diversity of T-cell receptor-gamma proteins expressed in mouse spleenR Q Cron, J E Coligan, J A Bluestone
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Activation of T cells in vivo using anti-CD3 and staphylococcal enterotoxinsJ A Bluestone, D S Bruce, K A Newell
Digestive Diseases and Sciences|January 1, 1995
Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptorsM L Alegre, D J Lenschow, J A Bluestone
Pageof 28